Pseudomonas aeruginosa secretes a rhamnolipid (RL) surfactant that functions in hydrophobic nutrient uptake, swarming motility and pathogenesis. We show that RhlA supplies the acyl moieties for RL biosynthesis by competing with the enzymes of type II fatty acid synthesis (FASII) for the β-hydroxyacyl-ACP pathway intermediates. Purified RhlA forms one molecule of β-hydroxydecanoyl-β-hydroxydecanoate from two molecules of β-hydroxydecanoyl-ACP and is the only enzyme required to generate the lipid component of RL. The acyl groups in RL are primarily β-hydroxydecanoyl and in vitro RhlA has a greater affinity for 10-carbon substrates illustrating that RhlA functions as a molecular ruler that selectively extracts 10-carbon intermediates from FASII.
Although RhlA is clearly a necessary step in the formation of the lipid moiety of rhamnolipid, the precise biochemical function of the rhlA gene product remains unclear. The stereochemistry of the β-hydroxyacids in HAA matches that of the intermediates in fatty acid biosynthesis as opposed to the intermediates in fatty acid β-oxidation ( Fig. 1) suggesting that fatty acid synthesis may be the source for the HAA. However, it is not known if RhlA is responsible for diversion of the intermediates from the biosynthetic pathway via a transacylation reaction to CoA, or the acyltransferase activity that forms HAA. The goal of this work was to assign the role of RhlA in rhamnolipid biosynthesis based on the biochemical properties of the purified RhlA protein and the products produced by heterologous expression in an Escherichia coli host. These experiments show that RhlA directly utilizes β-hydroxydecanoyl-ACP intermediates in fatty acid synthesis to generate the HAA portion of rhamnolipids.
MATERIALS AND METHODS

Materials.
Sources of supplies were: American Radiolabeled Chemicals Inc., [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]acetate (specific activity, 56 mCi/mmol), β-hydroxy [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]decanoyl-CoA (specific activity, 55 Ci/mol) and [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]octanoyl-CoA (specific activity, 50 mCi/mmol); Amersham Pharmacia Biotech, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]malonylCoA (specific activity, 52 mCi/mmol). ACP and the His-tagged fatty acid biosynthetic enzymes were purified as described previously by affinity chromatography followed by gel filtration chromatography (5, 10) . All other chemicals were reagent grade or better.
Construction of mutants and plasmids.
Sources for the strains and plasmids are given in 
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on September 23, 2017 by guest http://jb.asm.org/ Downloaded from TACAAGAAAGCTGGGTAGAGATGAAAACCGCCGTCGAT) were used to amplify the 302 bp fragment at 3′-end of rhlG. The four primers used for insertion of the gentamycin cassette between the above two fragments were described previously (4, 35) . Genotyping primers were: p1L: 5′- containing gentamycin (50 μg/ml) and carbenicillin (150 μg/ml). Merodiploids formed via a single crossover event was resolved through 5% sucrose selection in the presence of gentamycin. The
Gm marker was subsequently removed by Flp recombinase and a recombinase target FRT (85 bp) was left on chromosome. The rhlG deletion in strain KZ1 was verified by PCR utilizing genotypeing primers located outside and inside of rhlG. P. aeruginosa PAO1 strain KZ2 (rhlG::Gm) was created using the same method except the Gm marker was not excised by Flp recombinase.
Swarming plates were prepared with M8 minimal medium (6 g Na 2 HPO 4 , 2 g KH 2 PO 4 , 0.5 g NaCl per liter) supplemented with MgSO 4 (1 mM), glucose (0.2%) and casamino acids (0.5%), and solidified with 0.6% agar (2).
The coding region of rhlA from strain PA14 was amplified by PCR and cloned into pET28 (Novagen) NdeI/EcoRI restriction sites to yield an inducible rhlA expression plasmid, pKZ002.
Plasmid pPJ-kana was derived from pBluescript II KS + by replacing the ampicillin cassette with a kanamycin cassette. The DNA fragment containing the rhlA gene was recovered from pET28-rhlA using XbaI/EcoRI and cloned into pPJ-kana to give pKZ003. The coding region of the rhlB in strain PA14 was amplified by PCR and cloned into pBluescript II KS + EcoRI/HindIII sites to yield pKZ004. converting them to fatty acid methyl esters using HCl/methanol. The fatty acid methyl esters were identified and quantitated using a Hewlett-Packard Model 5890 gas chromatograph. Production of rhamnolipid in the culture medium was measured by anthrone colorimetric reaction (33) . Briefly, a 100 μl aliquot of the culture supernatant was mixed with 1 ml of anthrone reagent (0.1% in 70% H 2 SO 4 ) and incubated at 80°C for 30 min. After cooling to 25°C, the absorbance was read at 625 nm. The rhamnose concentration was obtained using a rhamnose standard curve. PhosphoImager.
RESULTS
Production of HAA and rhamnolipid in E. coli. The RhlA and RhlB proteins were expressed in E. coli to confirm that these two gene products were sufficient for RL1 production. The expression of RhlA from plasmid pKZ003 in BL21(DE3) led to accumulation of an extracellular lipid identified as HAA based on its migration on thin-layer chromatography in Silica Gel-coated rods ( Fig. 2A) . Accordingly, base-catalyzed hydrolysis of the HAA gave rise to a slower migrating band that co-migrated with β-hydroxydecanoic acid. Mass spectrometry of the HAA sample confirmed this identification showing a prominent peak at m/z 357 corresponding to an HAA consisting of two β-hydroxydecanoates, and minor peaks with molecular masses indicating the presence of a dimer between either 8-and 10-carbon, or a 10 and 12 carbon hydroxyl fatty acids (not shown). The HAA fraction was purified by thin-layer chromatography and analyzed by gas chromatography of the derived methyl esters (Fig. 2B) . HAA was composed primarily of β-hydroxydecanoic acid (95%) and β-hydroxydodecanoic acid (4%). Thus, HAA was the product of RhlA expression in culture supernatants.
The sugar moiety of rhamnolipid is derived from dTDP-L-rhamnose, and E. coli contains an operon that directs dTDP-L-rhamnose synthesis (23, 31) . The co-expression of RhlB and RhlA led consisting primarily of two β-hydroxydecanoyl moieties and one rhamnose (m/z = 503) (not shown). The total amount of HAA produced by E. coli strain BL21 expressing RhlA was less than the total HAA (HAA + RL1 + RL2) produced by wild-type P. aeruginosa strains PA14 and PAO1, even when RhlA expression was induced using plasmid pKZ002 (Table 2) . When RhlA and RhlB were expressed from the same promoter, the production of HAA was reduced due to the lower expression of RhlA (pKZ003), but the HAA formed was efficiently converted to RL1 (Table 2 ).
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Strain BL21 (E. coli B) produced significantly higher levels of HAA and RL1 than strain UB1005 (E.
coli K12) ( Table 2 ). The production of RL1 by E. coli K-12 strain W3110 expressing RhlAB was reported previously (1), and the reason for this difference between the formation of HAA and RL1
in E. coli K-12 and B strains harboring the same plasmids was not apparent.
RhlA enzymatic activity. It was not clear why the E. coli B strain permits HAA production while the K12 derivative does not, but one possibility was that strain BL21 possesses an enzyme, such as an acyl-ACP:CoA transacylase, that was not present in K12 strains, and was required to supply substrates to RhlA. Therefore, an in vitro assay system was designed to determine whether RhlA was responsible for the diversion of fatty acid biosynthetic intermediates to HAA formation.
His-tagged RhlA was purified to homogeneity by Ni 2+ -affinity chromatography followed by Superdex 200 gel filtration chromatography (Fig. 3A) . SDS gel electrophoresis revealed the presence of a 34 kDa protein, consistent with the subunit molecular weight predicted from the amino acid sequence of the recombinant RhlA (Fig. 3A, right inset) . The elution volume of RhlA on the gel filtration column suggested RhlA is a monomer in solution based on the calibration of the column with globular protein standards (Fig. 3A, left inset) . The intact mass spectrum of the purified protein gave a molecular weight of 34,964 corresponding to the His-tagged RhlA protein minus the amino-terminal fMet residue (Fig. 3B) . A coupled system was used to assess RhlA activity in vitro. First, β-[ C-labeled HAA isolated from the medium of strain BL21/pKZ003 (Fig. 4A, lane 5) .
Thus, purified RhlA was the only enzyme required to produce HAA from β-hydroxydecanoyl-ACP.
We did not detect the formation of HAA by RhlA using β-hydroxydecanoyl-CoA as the substrate using RhlA concentrations up to 10-times higher than we used to detect robust RhlA activity with the β-hydroxydecanoyl-ACP substrate.
Our work, and others (8), showed that 10-carbon fatty acids were the most abundant constituents in the HAA moiety of rhamnolipids. These data suggested that RhlA functioned as a molecular ruler to divert 10-carbon intermediates to HAA. Accordingly, RhlA exhibited a high degree of substrate selectivity in vitro (Fig. 4B) . The highest activity was obtained with β-hydroxydecanoyl ACP (136.0 ± 5.9 pmol/min/μg), with the activity falling off sharply either two carbons shorter (β-hydroxyoctanoyl-ACP, 9.8% compared to β-hydroxydecanoyl-ACP) or two carbons longer (β-hydroxydodecanoyl-ACP, 4.7% compared to β-hydroxydecanoyl-ACP) (Fig. 4B) .
Thus, the substrate specificity of RhlA accounted for the predominance of 10-carbon β-hydroxyacids characteristic of rhamnolipids produced in vivo (7, 16) . intermediates, and the activity of FabI is critical to pull the β-hydroxyacyl-ACP to acyl-ACP (10). In P. aeruginosa, neither of these genes is essential, but we surmised that their inactivation may slow the rate of β-hydroxydecanoyl-ACP utilization by fatty acid synthesis and allow RhlA greater access to β-hydroxy intermediates. Accordingly, strain PAO652 (ΔfabA) produced 55% more HAA for rhamnolipid than strain PAO1, and strain P39482 (fabI::Tn) produced 36% more HAA for rhamnolipid than strain PA14 (Table 2 ). Strain PAO1 was more efficient at converting HAA to rhamnolipid than strain PA14. These data indicated that restricting the activity of the enzymes responsible for the conversion of β-hydroxyacyl-ACP to acyl-ACP allowed a higher percentage of the pathway intermediates to be diverted to rhamnolipid production.
RhlG is not involved in rhamnolipid production. Previous work identified the rhlG gene as
an essential component for rhamnolipid formation based on the lack of extracellular rhamnolipid in rhlG deletion strains (3) . These data led to the conclusion that RhlG is the enzyme responsible for draining the fatty acid precursors of rhamnolipids away from the central type II fatty acid biosynthetic pathway (3, 21, 30) . We investigated this connection by generating strain KZ1 in strain PA14 with a deleted rhlG gene as diagramed in Fig. 6A . The presence of the deletions was confirmed by PCR analysis of the genomic DNA (Fig. 6B) . The ΔrhlG strain exhibited normal swarming ability, a property that is dependent on rhamnolipid secretion (Fig. 6C) . Testing the strains on individual swarming plates gave the same result. We also constructed an rhlG deletion in strain PAO1 (strain KZ2), and obtained rhlG transposon insertion strains in both strains PA14
and PAO1 from the P. aeruginosa mutant strain collections (15, 18) . All of these knockouts produced a normal amount of extracellular rhamnolipid (Fig. 6D) . We obtained strain ACP5, the
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on September 23, 2017 by guest http://jb.asm.org/ Downloaded from putative rhlG knockout in strain PAO1 that was used to show the connection between RhlG and rhamnolipid production (3). Although strain ACP5 had the expected tetracycline resistance, it had a wild-type rhlG gene based on DNA sequencing and secreted normal amounts of extracellular rhamnolipid. In addition, the biochemical analysis of the purified RhlG showed that this enzyme did not prefer ACP thioesters as substrate (19) .
DISCUSSION
Our experiments lead to a simplified model for the production of rhamnolipids in P. aeruginosa the E. coli model (1, 29) . In our experiments, HAA was as efficiently converted to rhamnolipid as it is in P. aeruginosa, although the total production of HAA was not as great. Taken together, these observations lead to the conclusion that the genetic regulation of RhlA expression is the only requirement for the initiation of HAA formation for rhamnolipid synthesis in P. aeruginosa.
Our data rule out the involvement of two other proteins that have been considered to participate in diverting β-hydroxydecanoyl-ACP to rhamnolipid formation. One idea was that rhamnolipids and poly-β-hydroxyalkanoates (PHA) are derived from a common β-hydroxydecanoyl-CoA pool (8,27).
It is clear that the PHA synthase (PhaC) utilizes acyl-CoA thioesters and that PhaG is an essential gene in PHA synthesis and functions as a transacylase to convert β-hydroxydecanoyl-ACP to β-hydroxydecanoyl-CoA (13, 26) . The utilization of CoA thioesters for PHA synthesis allows carbon from β-oxidation to enter PHA via the (R)-specific enoyl-CoA hydratases (32) . However, fatty acid synthesis is the only source for RL acyl chains in our model. Thus, the balance between rhamnolipid and PHA synthesis from the fatty acid biosynthetic pathway is determined by the competition between PhaG and RhlA for β-hydroxyacyl-ACP intermediates. An notable negative finding was that the rhlG gene is not involved in rhamnolipid synthesis and the published metabolic pathways to rhamnolipid involving a step catalyzed by RhlG (3, 8, 30) are not correct. Not only is
RhlG not required for rhamnolipid formation in the heterologous host E. coli, we were unable to reproduce the published results (3) implicating RhlG in rhamnolipid production using four different rhlG knockout strains of P. aeruginosa strains PAO1 and PA14. The fact that RhlG does not efficiently recognize acyl-ACP substrates (19) supports the idea that it is not involved in the metabolism of fatty acid synthase intermediates. Thus, RhlG plays no role in rhamnolipid formation and its physiological substrate remains to be identified. The indicated strains P. aeruginosa and E. coli were grown in M9 minimal salts medium with 0.4% glycerol as carbon source (20, 28) to a density of 5 x 10 8 cells/ml, the cellfree media were extracted and the concentration of each component was quantitated by flame-ionization detection following their separation by thin-layer chromatography as described under Materials and Methods. 
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